Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kingstone Schweizer Ventures is a venture capital organization established as a joint venture between Schweizer Kapital and KINGSTONE Capital Partners. The firm is dedicated to impact investments, particularly in sectors addressing the climate crisis. Although the specific founding date and location are not disclosed, the firm operates primarily out of Düsseldorf, Germany. Kingstone Schweizer Ventures has a combined assets under management (AUM) exceeding €2 billion, reflecting the resources of both parent entities.
The firm emphasizes a rigorous evaluation process for investment opportunities, supported by a scientific advisory board that includes experts from various fields. This structure allows Kingstone Schweizer Ventures to maintain a strong focus on innovative solutions that can deliver significant societal impact. The firm is committed to fostering interdisciplinary collaboration to maximize the effectiveness of its investments.
Kingstone Schweizer Ventures invests across multiple sectors, including climate technology, biotech, healthcare, and artificial intelligence. The firm primarily targets early-to-growth stage companies that are pioneering disruptive approaches within the impact investment landscape. Investment checks are expected to align with the firm’s commitment to combining financial returns with measurable positive impact, although specific check sizes are not disclosed.
The firm’s investment strategy emphasizes scientific rigor and interdisciplinary approaches to tackle pressing environmental challenges. Kingstone Schweizer Ventures seeks to support innovative solutions that not only promise financial success but also contribute positively to society and the environment. This dual focus on impact and returns distinguishes the firm in the competitive venture capital space.
Currently, Kingstone Schweizer Ventures does not have any notable portfolio companies listed. The firm is in the early stages of building its investment portfolio, focusing on identifying and supporting innovative startups that align with its impact investment strategy.
While there are no specific companies to highlight at this time, the firm’s commitment to sectors such as climate technology, biotech, healthcare, and AI suggests that future investments will likely target startups that are addressing significant societal challenges. The absence of current portfolio companies reflects the firm’s strategic approach to carefully vetting opportunities before making investments.
Umut Ertan - Co-founder. He represents the Schweizer Kapital family office based in Zurich and brings extensive experience in investment management.
Philipp Schomberg - Co-founder. He is associated with KINGSTONE Capital Partners and has a background in venture capital.
Dr. Tim Schomberg - Co-founder. Also from KINGSTONE Capital Partners, he contributes to the firm’s strategic direction and investment decisions.
Alexander Hoffmann - Managing Director. Previously served as Investment Director at M Ventures, the corporate venture capital arm of Merck, where he focused on scientific, pharmaceutical, and deep-tech investments.
Prof. Dr. Mark Post - Member of the Scientific Advisory Board. He is a co-founder of Mosa Meat and an expert in cellular agriculture.
Prof. Simone Stürwald - Member of the Scientific Advisory Board. She is affiliated with Eastern Switzerland University of Applied Sciences and brings expertise in applied sciences.
Prof. Dr. Herwig Buchholz - Member of the Scientific Advisory Board. He is associated with Merck KGaA and contributes his knowledge in scientific research and development.
As of April 2026, Kingstone Schweizer Ventures has not publicly announced any specific investments, exits, or fund raises. The firm is in the process of establishing its portfolio and is focused on identifying impactful investment opportunities.
Recent activities include the formation of the joint venture between Schweizer Kapital and KINGSTONE Capital Partners, which aims to create a rigorous venture capital strategy focused on impact investments.
What are Kingstone Schweizer Ventures' investment criteria?
The firm focuses on early-to-growth stage companies in sectors such as climate technology, biotech, healthcare, and AI. Kingstone Schweizer Ventures seeks innovative solutions that can deliver both financial returns and measurable societal impact.
How can founders apply or pitch to Kingstone Schweizer Ventures?
Currently, there is no specific application process or pitch portal mentioned. Founders are encouraged to reach out through professional networks or direct introductions to the firm’s partners.
What makes Kingstone Schweizer Ventures different from other venture capital firms?
The firm distinguishes itself through its rigorous scientific evaluation process, supported by a scientific advisory board. This approach ensures that investment opportunities are thoroughly vetted for their potential impact on addressing climate challenges.
What is the geographic focus of Kingstone Schweizer Ventures?
While specific geographic details are not provided, the firm operates primarily out of Düsseldorf, Germany, and is implied to focus on investments within Europe.
What is the typical check size for investments?
Specific check sizes are not disclosed, but the firm’s investment strategy suggests that it aligns with the early-to-growth stage funding requirements of its target sectors.
What kind of post-investment involvement can portfolio companies expect?
Kingstone Schweizer Ventures adds value through its scientific advisory board, providing expertise and guidance to portfolio companies as they scale their innovative solutions.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.